Latest news
Loading news…
Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.
Revance Therapeutics was acquired by Crown Laboratories in 2024 for $924M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
522
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Newark, California, United States
Acquisitions by Revance Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Revance Therapeutics
Vice President, Platform Research and Development
Chief Medical Officer
Vice President of Data-Decisioning | Data Innovation | Data Stewardship | Decision Science
Head of Product Design and Creative
Chief Executive Officer
Director
Executive Vice President and Chief Revenue Officer - Aesthetics and Therapeutics
Founder and Chief Executive Officer
COO, President of R&D and Product Operations
President
522
professional contacts at Revance Therapeutics
Contact execs at Revance Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Revance Therapeutics
Loading news…
FAQs about Revance Therapeutics
People who checked this page also checked these
Sectors Revance Therapeutics invests & acquires in
Browse the full Acquirezy directory.